360o Virtual Tour360<sup>o</sup> Virtual Tour
Speak to Our Experts

Cell engineering services at Aurigene cater to both tool/reagent and biological product development requirements. We have strong expertise to generate recombinant/stable cell lines for complex and wide protein class targets like RTKs, GPCRs, ion channels, immune modulation ligands/receptors, Fc-gamma receptors, GPI-anchored, TNF-receptor superfamily, cell adhesion molecules, transporters, co-receptors, and reporter genes. We are well versed in working with different cellular backgrounds such as established cancer cell lines, primary cells, etc. Hard-to-transfect cell lines required for binding studies, functional assays, immunization in vitro/in vivo screening and efficacy evaluation applications are successfully engineered to achieve the desired attributes.

For biologic programs, we have experience of product development for mAbs, immune-fusion molecules, cytokines, etc. The typical activities include transfection, selection, limiting dilution, media/feed screening, cell line characterization, research cell banking and protein production. We have the experience of multiple production platforms.

The key cell engineering service offerings are listed below:

  • Membrane-bound receptor cell lines with expression calibrated clones (low, medium, and high)
  • Receptor density measured and clones selected as per end-use requirement
  • Knock-In (KI), Knock-Down (KD) and Knock-Out (KO) cell lines using siRNA / shRNA & CRISPR/Cas9 or TALEN technologies
  • Single, double, or multiple gene KO / KD in primary and established cell lines
  • Inducible cell line using Tet / Cumate inducible system
  • Reporter cell lines (Fluorescent protein / Luciferase)
  • Orthotopic cell line for in vivo xenograft and imaging applications
  • Production cell lines using commercially available systems like Freedom CHO-S/CHO DG44/CHOZN & in-house developed lentiviral system
  • SARS-CoV-2 Pseudovirus generation and neutralization assay
  • Vector systems: pcDNA series, pLVX and pGIPZ / pTRIPZ lentiviral vector series, pCHO1.0, pOptivec, pGL and in-house modified vector systems
  • Transfection methods: Standard (Lipid/nanoparticle), Electroporation, Transposon and Lentiviral transduction
  • Screening methods: Flow cytometry, Western blot, PA-HPLC, ELISA, Octet and ClonePix
  • Quality Check: Thaw test, Mycoplasma, Clonal stability, Receptor density estimation, SE-HPLC and LC-MS analysis

Aurigene Pharmaceutical Services is

a leading CDMO/CRO

that provides contract research and manufacturing services



Cell Engineering

Read More

Virtual Tour

Contact Us

1 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

You are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.

If you wish to continue to this external website, click Proceed.